ba0007lb4 | (1) | ICCBH2019
Shepherd Sheila
, Dewantoro Dixon
, Ahmed Syed Faisal
, Gerasimidis Kostas
, Mason Avril
, Shaikh Guftar
, Wong SC
, Kyriakou Andreas
Introduction: Pubertal suppression with gonadotrophin releasing hormone (GnRH) analogue is introduced after onset of puberty in adolescents with gender dysphoria (GD). As puberty is a critical period for bone accrual and changes in body composition, alterations in body composition and bone mass may be observed during treatment.Methods: Thirty-eight adolescents (32/38 assigned females at birth) with GD had dual energy X-ray absorptiometry (DXA) prior to s...